首页> 美国卫生研究院文献>BMJ Open >Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children adolescents and adults: protocol for a systematic review and network meta-analysis
【2h】

Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children adolescents and adults: protocol for a systematic review and network meta-analysis

机译:药物干预对儿童青少年和成人注意力缺陷/多动障碍的比较功效和耐受性:系统评价和网络荟萃分析的方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionAttention-deficit/hyperactivity disorder (ADHD) is a major public health issue. Pharmacological treatments play an important role in the multimodal treatment of ADHD. Currently, there is a lack of up-to-date and comprehensive evidence on how available ADHD drugs compare and rank in terms of efficacy and tolerability, in children or adolescents as well as in adults. We will conduct a network meta-analysis (NMA), integrating direct and indirect comparisons from randomised controlled trials (RCTs), to rank pharmacological treatments for ADHD according to their efficacy and tolerability profiles.
机译:简介注意缺陷/多动障碍(ADHD)是主要的公共卫生问题。药物治疗在多动症的多模式治疗中起重要作用。当前,关于儿童或青少年以及成人中ADHD药物如何在功效和耐受性方面进行比较和排名,目前缺乏最新和全面的证据。我们将进行网络荟萃分析(NMA),整合来自随机对照试验(RCT)的直接和间接比较,以根据ADHD的疗效和耐受性对药物治疗进行排名。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号